| |
 |
|
Class Information
Number: 424/241.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) > Escherichia (e.g., escherichia coli, etc.)
Description: Subject matter wherein the toxin or toxoid originates from a bacterium of the genus Escherichia.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7371393 |
Methods for reducing fecal shedding |
May. 13, 2008 |
| 7341732 |
Methods for treating mastitis in a milk producing animal |
Mar. 11, 2008 |
| 7332172 |
Transformed bacteria producing CS6 antigens as vaccines |
Feb. 19, 2008 |
| 7323179 |
Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
Jan. 29, 2008 |
| 7309493 |
Inactivated bovine scours vaccines, process and method of preventing bovine scours |
Dec. 18, 2007 |
| 7247307 |
Vaccines against Escherichia coli O157 infection |
Jul. 24, 2007 |
| 7214499 |
Pathogenic Escherichia coli associated protein |
May. 8, 2007 |
| 7189557 |
Process for the intracellular over-production of streptokinase using genetically engineered strain of E. coli |
Mar. 13, 2007 |
| 7160549 |
Methods for making compositions including gram negative microbial polypeptides |
Jan. 9, 2007 |
| 7147857 |
Methods for treating high somatic cell counts |
Dec. 12, 2006 |
| 7138124 |
Polypeptides obtained from gram negative microbes |
Nov. 21, 2006 |
| 7138125 |
Methods for treating an animal for low milk production |
Nov. 21, 2006 |
| 7118758 |
Transformed bacteria producing CS6 antigens as vaccines |
Oct. 10, 2006 |
| 7097845 |
Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
Aug. 29, 2006 |
| 7056521 |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
Jun. 6, 2006 |
| 7037499 |
Adjuvant for transcutaneous immunization |
May. 2, 2006 |
| 7025971 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Apr. 11, 2006 |
| 7018636 |
Vaccine against Gram-negative bacterial infections |
Mar. 28, 2006 |
| 7014857 |
Anti-sepsis conjugate vaccine |
Mar. 21, 2006 |
| 6974577 |
Inactivated bovine scours vaccines, processes and method of preventing bovine scours |
Dec. 13, 2005 |
| 6962791 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Nov. 8, 2005 |
| 6951652 |
Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases |
Oct. 4, 2005 |
| 6872542 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Mar. 29, 2005 |
| 6844423 |
Compositions and methods for regulating bacterial pathogenesis |
Jan. 18, 2005 |
| 6841345 |
Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A |
Jan. 11, 2005 |
| 6835710 |
Verotoxin pharmaceutical compositions and medical treatments therewith |
Dec. 28, 2004 |
| 6833451 |
Lipopolysaccharides (LPS) extracted from Escherichia coli |
Dec. 21, 2004 |
| 6824997 |
Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
Nov. 30, 2004 |
| 6818222 |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
Nov. 16, 2004 |
| 6797276 |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
Sep. 28, 2004 |
| 6797272 |
Enhanced immunogenicity using leukotoxin chimeras |
Sep. 28, 2004 |
| 6793928 |
Vaccines with an LTB adjuvant |
Sep. 21, 2004 |
| 6790446 |
Campylobacter vaccine |
Sep. 14, 2004 |
| 6780414 |
METHODS OF IDENTIFYING BACTERIAL GENES THAT ARE INCOMPATIBLE WITH BACTERIAL PATHOGENICITY, AND THE USE OF SUCH GENES, SUCH AS CADA, TO REDUCE PATHOGENICITY IN A BACTERIA OR TO COMBAT PATHOGENI |
Aug. 24, 2004 |
| 6764687 |
Live attenuated bacteria for use in a vaccine |
Jul. 20, 2004 |
| 6749831 |
Vaccine against lipopolysaccharide core |
Jun. 15, 2004 |
| 6696065 |
Acellular pertussis vaccines and methods of preparation thereof |
Feb. 24, 2004 |
| 6635259 |
Escherichia coli secreted protein B |
Oct. 21, 2003 |
| 6632437 |
Immunogenic polysaccharide-protein conjugates containing poly .alpha.(2.fwdarw.8), .alpha.(2.fwdarw.9) NeuNAc capsular polysaccharides |
Oct. 14, 2003 |
| 6596504 |
Treatment of prophylaxis of diseases caused by pilus-forming bacteria |
Jul. 22, 2003 |
| 6585980 |
Flagellin gene, FlaC of Campylobacter |
Jul. 1, 2003 |
| 6548265 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Apr. 15, 2003 |
| 6548287 |
Non-pyrogenic bacterial strains and use of the same |
Apr. 15, 2003 |
| 6541013 |
Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide |
Apr. 1, 2003 |
| 6537558 |
Methods of producing and using virulence attenuated poxR mutant bacteria |
Mar. 25, 2003 |
| 6517829 |
Products comprising inactivated yeasts or moulds provided with active antibodies |
Feb. 11, 2003 |
| 6500434 |
Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections |
Dec. 31, 2002 |
| 6486132 |
Immunomodulator, immunomodulator food and immunomodulator feed |
Nov. 26, 2002 |
| 6471966 |
Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof |
Oct. 29, 2002 |
| 6440423 |
Mutant enterotoxin effective as a non-toxic oral adjuvant |
Aug. 27, 2002 |
|
|
|
